OTC label reform to be subject of "feedback" meetings by product category.
This article was originally published in The Tan Sheet
Executive Summary
OTC LABEL-REFORM "FEEDBACK" MEETINGS LIKELY TO KICK OFF WITH ANTACIDS, and will be followed by meetings between FDA and industry addressing standardized labeling for other over-the-counter drug product categories. A meeting on OTC internal analgesic labeling also is expected to be among the first "feedback" meetings in the series.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning